Piramal Enterprises has informed about a Press Release dated January 30, 2017 titled ‘Piramal Enterprises announces Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC’.
The above information is a part of company’s filings submitted to BSE.